» Articles » PMID: 5660301

Medullary Carcinoma of the Thyroid Gland. Studies of Thyrocalcitonin in Plasma and Tumor Extracts

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1968 Aug 8
PMID 5660301
Citations 26
Authors
Affiliations
Soon will be listed here.
Citing Articles

Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.

Jiao Z, Wu T, Jiang M, Jiang S, Jiang K, Peng J Front Endocrinol (Lausanne). 2023; 13:1094242.

PMID: 36589824 PMC: 9800993. DOI: 10.3389/fendo.2022.1094242.


International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma.

Xu B, Fuchs T, Ahmadi S, Alghamdi M, Alzumaili B, Bani M J Clin Oncol. 2021; 40(1):96-104.

PMID: 34731032 PMC: 8683221. DOI: 10.1200/JCO.21.01329.


Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome.

Alzumaili B, Xu B, Spanheimer P, Tuttle R, Sherman E, Katabi N Mod Pathol. 2020; 33(9):1690-1701.

PMID: 32313184 PMC: 7483270. DOI: 10.1038/s41379-020-0532-1.


Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

Thomas C, Asa S, Ezzat S, Sawka A, Goldstein D Curr Oncol. 2019; 26(5):338-344.

PMID: 31708652 PMC: 6821118. DOI: 10.3747/co.26.5539.


Medullary Thyroid Carcinoma: Why Is Specialization Mandatory?.

Weber T Visc Med. 2019; 34(6):419-421.

PMID: 30675485 PMC: 6341351. DOI: 10.1159/000493809.